Herry Robert Mapesi

In the News

Malaria: Call for action to curb insecticide resistance

Ifakara Health Institute (IHI) scientist Gerry Killeen has called for the international community to be bolder in adopting new products for existing interventions such as insecticide treated bed nets, so …

Muhas don is new IHI board member

Prof. Kaaya. Ifakara Health Institute (IHI) Board of Governors (BOG) has appointed Prof. Sylvia Kaaya member of the IHI Board of Trustees (BOT) effective Wednesday January 10, 2018. The appointment …

Recent Projects

Development of a new tool for malaria mosquito surveillance to improve vector control

Malaria transmission is influenced not only by vector abundance, but as well by demographic traits such as vector species and age structure, as these influence the intensity by which the …

Demonstrating complete disruption of residual malaria transmission by eliminating Anopheles funestus mosquitoes from rural Tanzanian villages

In rural south-eastern Tanzania, where malaria prevalence has reduced by >60% since 2000, low-to-moderate transmission still persists despite very high coverage with long-lasting insecticidal bednets. Like in most residual transmission …

Herry Robert Mapesi

Research Scientist & Clinician

Dr. Herry Robert Mapesi is a Clinician and the Deputy Head of the Chronic Diseases Clinic of Ifakara (CDCI). He obtained his medical degree from Hubert Kairuki Memorial University in 2012 and joined the Ifakara Health Institute in 2013. He also has a Masters degree in Epidemiology from the University of Basel, Switzerland, since January 2017.  Dr. Mapesi is interested in kidney infections among HIV-infected patients and is currently working on a project to determine risk factors associated with kidney outcomes among newly diagnosed HIV patients in rural Tanzania. He has previously been involved in other projects such as, An Integrated and Comprehensive Service Delivery Model to Improve Paediatric and Maternal HIV Care, a study on adherence to Anti-Retroviral Therapy (ART) among HIV-infected patients and lastly prevalence and risk factors associated with different co-morbidities among HIV-infected patients. He provides treatment and care service to people living with HIV. Dr. Mapesi is trained in Advanced HIV and  European Clinical Research Courses sponsored by the European Aids Clinical Society. He has presented his findings in national and international conferences such as the 9th European Congress of Tropical Medicine and International Health in Basel, Switzerland and the 4th Muhimbili scientific conference in Dar es salaam, Tanzania.

View Dr. Mapesi’s Research Interests and Publications

Projects

Epidemiology and molecular monitoring of HIV drug resistance in Tanzania

Kilombero and Ulanga antiretroviral cohort study (KIULARCO)

Evaluation of Lopinavir-based anti-retroviral therapy for HIV-Infected children: a phase IIIb clinical trial in Ifakara

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016